SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-22-106857
Filing Date
2022-04-15
Accepted
2022-04-15 16:35:58
Documents
13
Period of Report
2022-04-12
Items
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d305048d8k.htm   iXBRL 8-K 26743
2 EX-3.1 d305048dex31.htm EX-3.1 125470
  Complete submission text file 0001193125-22-106857.txt   302507

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA sgen-20220412.xsd EX-101.SCH 2882
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE sgen-20220412_lab.xml EX-101.LAB 17982
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE sgen-20220412_pre.xml EX-101.PRE 11276
7 EXTRACTED XBRL INSTANCE DOCUMENT d305048d8k_htm.xml XML 3415
Mailing Address 21823 30TH DRIVE SE SUITE BOTHELL WA 98021
Business Address 21823 30TH DRIVE SE SUITE BOTHELL WA 98021 4255274000
Seagen Inc. (Filer) CIK: 0001060736 (see all company filings)

IRS No.: 911874389 | State of Incorp.: WA | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-32405 | Film No.: 22830383
SIC: 2836 Biological Products, (No Diagnostic Substances)